Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Jiaping Zheng"'
Autor:
Tingting Zhang, Chao Meng, Wei He, Tao Xu, Yi Yang, Chongqi Tu, Ling Zhang, Xiaofeng Sun, Chunrong Zhu, Xueyi Dang, Ke Wang, Chuan Chen, Xiong Yan, Huiting Xu, Le Huang, Enlai Jiang, Feng Xia, Xinming Zhou, Shunkai Zhou, Weidong Zang, Xifeng Li, Jin Zhang, Jiaping Zheng, Jianjun Xin, Bin Huang, Guopei Zhu, Jiexiang Zhu, Jun Liang
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Data on long-term cancer survivors treated with apatinib are lacking. This study aimed to describe the characteristics of long-term cancer survivors after apatinib-based therapy, and to know about their satisfaction degree with ap
Externí odkaz:
https://doaj.org/article/20f039f7b7e74a27bbfeddfa4061b205
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Currently, there is no consensus on the treatment of recurrent hepatocellular carcinoma (HCC) after hepatectomy. It is necessary to assess the efficacy and safety of radiofrequency ablation (RFA) combined with iodine-125 seeds imp
Externí odkaz:
https://doaj.org/article/f1514eb08ee442159fbaee15cda0a94c
Autor:
Wei Wu, Zhen Bao, Kai Zhu, Danjun Song, Weijian Yang, Jun Luo, Jiaping Zheng, Guoliang Shao, Junfeng Huang
Publikováno v:
Heliyon, Vol 10, Iss 11, Pp e31968- (2024)
Objectives: The lymphotactin receptor X–C motif chemokine receptor 1 (XCR1) is an essential member of the chemokine receptor family and is related to tumor development and progression. Nevertheless, further investigation is required to explore its
Externí odkaz:
https://doaj.org/article/3fc64d65a2a84f56946cc75b961f6c35
Publikováno v:
Nutrition & Diabetes, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract Background and objectives Dietary control and increased physical activity (PA) are recommended for patients with metabolic (dysfunction-) associated fatty liver disease (MAFLD). However, not all patients can sustain both exercise and a healt
Externí odkaz:
https://doaj.org/article/507ef69e8c5245ea80b1c89a352faf92
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 18 (2024)
Background: Liver cancer has a high incidence and mortality rate worldwide, and there is an urgent need to identify new therapeutic strategies and predictive targets to improve the clinical outcomes of advanced liver cancer. Ferroptosis holds promise
Externí odkaz:
https://doaj.org/article/ba581cd7131b4fafa5188c6c179fe9a1
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Purpose The aim of the present study was to assess the efficacy and safety of transarterial chemoembolization (TACE) combined with atezolizumab and bevacizumab (hereafter, TACE-Atez/Bev) in the treatment of advanced hepatocellular carcinoma
Externí odkaz:
https://doaj.org/article/f0f33580c1894e0a909557708b13b1d1
Autor:
Jiaping Zheng, Xinyan Zhu, Guiqing Xu, Xingchen Wang, Mengyang Cao, Shusen Zhu, Rui Huang, Yu Zhou
Publikováno v:
Nutrition Journal, Vol 22, Iss 1, Pp 1-11 (2023)
Abstract Background Moderate caffeine intake decreases the risk of metabolic disorders and all-cause mortality, and the mechanism may be related to its ergogenic actions. Thyroid hormones are vital in metabolic homeostasis; however, their association
Externí odkaz:
https://doaj.org/article/9d6e2c10eef040e68cf29d5a99186c3a
Publikováno v:
Dose-Response, Vol 21 (2023)
Objectives To investigate the potential mechanisms of 125 I seed implantation therapeutic treatment on inactivating the VEGFR2/PI3K/AKT pathway in cholangiocarcinoma. Methods The human cholangiocarcinoma cell lines HCCC-9810 and HuCCT1 were purchased
Externí odkaz:
https://doaj.org/article/1b3fd0fe22784c09985947576f095781
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundMicrowave ablation (MWA) for hepatocellular carcinomas (HCCs) in the elderly has been the subject of new research in recent years. However, there are currently no strong lines of evidence for the prognosis following MWA treatment for HCC in
Externí odkaz:
https://doaj.org/article/369517fb0d694ec6a2f2871f2fa76409
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: The information is relatively scarce regarding the occurrence of drug-induced acute kidney injury (AKI) when anti-coronavirus disease 2019 (COVID-19) drugs are prescribed for patients with diabetes mellitus (DM).Objective: The objective o
Externí odkaz:
https://doaj.org/article/38746374b92b4f9a8571296cfadf8576